Trials / Terminated
TerminatedNCT03364686
Transfusion of Biotin-Labeled Red Blood Cells
Transfusion of Biotin-Labeled Red Blood Cells for the Evaluation of Genetic Factors That Contribute to Donor Differences in Red Blood Cell Storage and Post-Transfusion Red Blood Cell Recovery
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Gladwin, Mark, MD · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to evaluate the impact of genetic and biologic factors in blood donors on red blood cell storage stability after autologous transfusion over the different range of storage period of 5-7 days and 35-42 days in healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Biotin-Labeled Red Blood Cells | We will collect 500 mL of blood. The blood will be processed and split into two bags and labeled with a naturally occurring vitamin, biotin. The blood will then be re-infused back into the same participant at 2 time points (5-7 days and 35-42 days after storage). |
Timeline
- Start date
- 2019-09-16
- Primary completion
- 2021-03-02
- Completion
- 2021-06-29
- First posted
- 2017-12-06
- Last updated
- 2022-04-21
- Results posted
- 2022-04-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03364686. Inclusion in this directory is not an endorsement.